Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-synuclein: normal function and role in neurodegenerative diseases.

Erin H Norris1, Benoit I Giasson, Virginia M-Y Lee

  • 1Center for Neurodegenerative Disease Research and the Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Current Topics in Developmental Biology
|April 20, 2004
PubMed
Summary

Synucleins, particularly alpha-synuclein, are key proteins in neurodegenerative diseases like Parkinson's. Continued research is vital to understand their normal functions and disease roles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein.

Acta neuropathologica communications·2026
Same author

Rigorous evaluation of pathological α-synucleinopathy transmissibility between animals in an experimental model.

Acta neuropathologica communications·2026
Same author

Progressive Supranuclear Palsy PERK Haplotype B Selectively Translates DLX1 Promoting Tau Toxicity.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

C1q-dependent clearance of alpha-synuclein allows macrophages to transiently limit enteric synucleinopathy in male mice.

Nature communications·2026
Same author

Uncovering α-synuclein and tau burden in Alzheimer's and Lewy body diseases.

Brain communications·2025
Same author

An antibody targeting high-molecular-weight kininogen blocks contact system activation in a model of polymicrobial sepsis.

Journal of thrombosis and haemostasis : JTH·2025

Area of Science:

  • Neurobiology
  • Protein Biochemistry
  • Neurodegenerative Diseases

Background:

  • Synucleins are small, charged proteins primarily found in neurons.
  • Alpha-synuclein (alpha-syn) forms pathological inclusions in synucleinopathies.
  • Synucleinopathies include Parkinson's disease, dementia with Lewy bodies, and NBIA-1.

Purpose of the Study:

  • To review current knowledge on synuclein structure, function, and interactions.
  • To highlight the role of alpha-synuclein in neurodegenerative disease pathogenesis.
  • To emphasize the need for ongoing research into synucleinopathies.

Main Methods:

  • Literature review and synthesis of existing research on synucleins.
  • Analysis of genetic and biological studies implicating alpha-synuclein.

Related Experiment Videos

  • Characterization of synuclein protein structure and function.

    • Main Results:

    • Alpha-synuclein is a major component of Lewy bodies and related inclusions.
    • Genetic evidence links alpha-synuclein to the development of synucleinopathies.
    • Synuclein proteins have diverse interactions and potential physiological roles.

    Conclusions:

    • Alpha-synuclein plays a critical role in the pathophysiology of major neurodegenerative disorders.
    • Further investigation is required to elucidate synuclein functions in health and disease.
    • Understanding synucleins is crucial for developing treatments for synucleinopathies.